Saladax Biomedical Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Saladax Biomedical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12119
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, MyPaclitaxel is blood test used to measure exposure of patient to paclitaxel, and MyDocetaxel measures patient’s exposure to docetaxel. Saladax’s MyImatinib measures and helps physicians to optimize a patient’s exposure to imatinib. The company’s products are used in the treatment of cell lung cancer, digestive tract, prostate, and head and neck cancers. It markets its products in the US and abroad. Saladax is headquartered in Bethlehem, Pennsylvania, the US.

Saladax Biomedical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Saladax Biomedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Saladax Biomedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Saladax Biomedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Saladax Biomedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Saladax Biomedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Saladax Biomedical Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Saladax Biomedical Raises US$23 Million In Series D Venture Financing 10
Partnerships 12
Saladax Biomedical Enters into Licensing Agreement with Janssen Pharma 12
Siemens Healthcare Enters into Licensing Agreement with Saladax Biomedical 13
Saladax Biomedical Enters Into Distribution Agreement With Transmedic For Oncology Dosing Assays 14
Saladax Biomedical Expands Co-Development Agreement With Bristol-Myers Squibb 15
Saladax Biomedical Enters Into Co-Marketing Agreement With INyDIA Laboratorios Biomedical Diagnostics For My5-FU 16
Equity Offering 17
Saladax Biomedical Raises USD22.4 Million in Private Placement 17
Saladax Biomedical Inc – Key Competitors 18
Saladax Biomedical Inc – Key Employees 19
Saladax Biomedical Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Saladax Biomedical Inc, Medical Equipment, Key Facts 2
Saladax Biomedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Saladax Biomedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Saladax Biomedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Saladax Biomedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Saladax Biomedical Inc, Deals By Market, 2012 to YTD 2018 8
Saladax Biomedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Saladax Biomedical Raises US$23 Million In Series D Venture Financing 10
Saladax Biomedical Enters into Licensing Agreement with Janssen Pharma 12
Siemens Healthcare Enters into Licensing Agreement with Saladax Biomedical 13
Saladax Biomedical Enters Into Distribution Agreement With Transmedic For Oncology Dosing Assays 14
Saladax Biomedical Expands Co-Development Agreement With Bristol-Myers Squibb 15
Saladax Biomedical Enters Into Co-Marketing Agreement With INyDIA Laboratorios Biomedical Diagnostics For My5-FU 16
Saladax Biomedical Raises USD22.4 Million in Private Placement 17
Saladax Biomedical Inc, Key Competitors 18
Saladax Biomedical Inc, Key Employees 19

List of Figures
Saladax Biomedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Saladax Biomedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Saladax Biomedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Saladax Biomedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Saladax Biomedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Saladax Biomedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Saladax Biomedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Saladax Biomedical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Saladax Biomedical Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SAG. Solar GmbH & Co KG-エネルギー分野:企業M&A・提携分析
    Summary S.A.G. Solar GmbH & Co. KG. (S.A.G. Solar), a subsidiary of Shunfeng International Clean Energy Limited, is a manufacturer of photovoltaic systems. The company constructs, installs, operates and integrates solar power plants. It constructs rooftop systems, roof and facade-integrated systems, …
  • Medshape Inc-医療機器分野:企業M&A・提携分析
    Summary Medshape Inc (MedShape), formerly MedShape Solutions Inc is a medical device company that develops and manufactures orthopedic devices for the orthopedic healthcare markets. The company’s products include dynanail ankle arthrodesis nail, eclipse soft tissue anchor, exoshape teno soft tissue …
  • AxoGen Inc (AXGN):医療機器:M&Aディール及び事業提携情報
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among …
  • Eisai Inc:企業の戦略的SWOT分析
    Eisai Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • The Chemours Company, LLC:戦略・SWOT・企業財務分析
    The Chemours Company, LLC - Strategy, SWOT and Corporate Finance Report Summary The Chemours Company, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Wynn Resorts Ltd:戦略・SWOT・企業財務分析
    Wynn Resorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Wynn Resorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Vector Ltd (VCT):電力:M&Aディール及び事業提携情報
    Summary Vector Ltd (Vector), a subsidiary of Entrust, is a utility network provider. It offers power and telecommunication services. The company distributes electricity and gas in Auckland; stores and processes, and sells natural gas and LPG; and deploys electricity and gas meters to homes and busin …
  • Oneok Inc (OKE):企業の財務・戦略的SWOT分析
    Oneok Inc (OKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Crisil Ltd (CRISIL):企業の財務・戦略的SWOT分析
    Summary Crisil Ltd (Crisil), a subsidiary of S&P Global Inc is a financial service provider that offers risk management services. The company provides ratings, research and risk and policy advisory services. It offers services such as credit ratings, business school gradings, real estate star rating …
  • Cryogenmash:企業の戦略的SWOT分析
    Cryogenmash - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Standardkessel Baumgarte Holding GmbH:企業の戦略的SWOT分析
    Standardkessel Baumgarte Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Westinghouse Air Brake Technologies Corporation:企業の戦略・SWOT・財務情報
    Westinghouse Air Brake Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Westinghouse Air Brake Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Birks Group Inc (BGI):企業の財務・戦略的SWOT分析
    Birks Group Inc (BGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hexion Inc.:企業の戦略・SWOT・財務分析
    Hexion Inc. - Strategy, SWOT and Corporate Finance Report Summary Hexion Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Terna SpA (TRN)-エネルギー分野:企業M&A・提携分析
    Summary Terna S.p.A. (Terna) is an electricity transmission system operator (TSO). It operates high-voltage grid and carries out transmission and dispatching of electricity, maintains transmission infrastructure, plans and constructs the grid, and undertakes grid development projects. It offers spec …
  • Artilium plc (ARTA):企業の財務・戦略的SWOT分析
    Summary Artilium Plc (Artilium) is a technology company that offers mobile telecommunications software solutions. The company offers mobile virtual network enabler software solutions through its own state of the art cloud platform. It MVNE includes private LTE networks, MVNO in box, oneapp and multi …
  • Tetra Pak International SA:企業の戦略・SWOT・財務分析
    Tetra Pak International SA - Strategy, SWOT and Corporate Finance Report Summary Tetra Pak International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Thundelarra Ltd (THX):企業の財務・戦略的SWOT分析
    Summary Thundelarra Ltd (Thundelarra) is a mining and mineral exploration company. The company acquires, explores and develops lead, zinc, silver, nickel, graphite, copper, gold and uranium prospects in Western Australia and the Northern Territory. Its projects include Red Bore Copper-Gold Project, …
  • Vikas WSP Ltd (VIKASWSP):企業の財務・戦略的SWOT分析
    Vikas WSP Ltd (VIKASWSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • BioCat GmbH-医療機器分野:企業M&A・提携分析
    Summary BioCat GmbH (BioCat) is a medical device company that markets innovative products and services for life science research. The company provides products such as antibodies, epigenetics, PCR, cloning, viral systems, tissue-specific analysis, reporter assays, diabetes, fluorescent proteins, sam …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆